Clinical and genetic features of Chinese adult patients with tumour necrosis factor receptor-associated periodic fever syndrome

被引:10
|
作者
Zhao, Mengzhu [1 ]
Luo, Yi [1 ]
Wu, Di [1 ]
Yang, Yunjiao [1 ]
Sun, Yang [2 ]
Wang, Rongrong [2 ]
Shen, Min [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Key Lab Rheumatol & Clin Immunol,Minist Educ, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, McKusick Zhang Ctr Genet Med, Inst Basic Med Sci,Sch Basic Med,State Key Lab Me, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
TRAPS; TNFRSF1A gene; systemic autoinflammatory diseases; adult-onset; SYNDROME TRAPS; AUTOINFLAMMATORY DISEASE; BLAU SYNDROME; MUTATION; VARIANTS; FAMILY; JAPAN; GIRL;
D O I
10.1093/rheumatology/kez569
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: TNF receptor-associated periodic fever syndrome (TRAPS) is an autosomal dominant systemic autoinflammatory disease caused by mutations of TNF receptor superfamily member 1 A (TNFRSF1A) gene. TRAPS has hardly been reported in the Chinese population. We aimed to characterize the clinical and genetic features of Chinese adult patients with TRAPS. Methods: Nine adult patients (>= 16 years) were diagnosed during April 2015 to June 2019, at the Department of Rheumatology, Peking Union Medical College Hospital. Clinical and genetic features of these patients were evaluated and compared with those from Japan and Europe. Results: The median age of disease onset was 3 (0.5-38.5) years old, and adult-onset was observed in two (22.2%) patients. The median time of diagnosis delay was 16.5 (1.5-50.5) years. One patient had a family history of TRAPS. The frequent symptoms were fever (nine, 100%), rash (seven, 77.8%), arthralgia/arthritis (five, 55.6%) and abdominal pain (five, 55.6%). Only two (22.2%) patients had periorbital oedema. Nine TNFRSF1A gene variants were detected, including C58R, G65E, F89L, C99G, V202G, V202D, c.769-23T>C, S290I and c.*64T>C. Rash was more frequently seen in Chinese than in Japanese and European patients, while chest pain and amyloidosis occurred less frequently. Conclusion: This is the first and largest case series of TRAPS in Chinese adult patients. Two novel TNFRSF1A variants, S290I and V202G, have been identified. The different clinical manifestations of our patients compared with those from Japan and Europe might be related to their TNFRSF1A variants.
引用
收藏
页码:1969 / 1974
页数:6
相关论文
共 50 条
  • [21] Intra-abdominal abscess in a patient with tumour necrosis factor receptor-associated periodic syndrome
    Stjernberg-Salmela, S
    Kivisaari, A
    Puolakkainen, P
    Färkkilä, MF
    Kemppainen, E
    Ranki, A
    Pettersson, T
    JOURNAL OF INTERNAL MEDICINE, 2006, 259 (02) : 209 - 213
  • [22] Tumor necrosis factor receptor-associated periodic syndrome in a pediatric patient A genetic diagnosis
    Yakhmi, Neha
    Knutsen, Alan P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (04) : 369 - 371
  • [23] Adult-onset tumour necrosis factor receptor-associated periodic syndrome presenting as transfusion-dependent refractory haemophagocytosis
    Youngstein, Taryn
    Koh, Mickey B. C.
    Soto, Jose Ros
    Rowczenio, Dorota
    Trojer, Hadija
    Lachmann, Helen J.
    Sofat, Nidhi
    RHEUMATOLOGY, 2018, 57 (03) : 582 - 583
  • [24] Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome
    Drewe, E
    McDermott, EM
    Powell, RJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (14): : 1044 - 1045
  • [25] A novel mutation in TNFRSF1A associated with overlapping features of tumour necrosis factor receptor-associated periodic syndrome and hyper-IgD syndrome
    Saulsbury, F. T.
    Remmers, E. F.
    Aksentijevich, I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (01) : 94 - 96
  • [26] Differential serum levels of interleukin-37 in patients with tumour necrosis factor receptor-associated periodic syndrome (TRAPS)
    Lucherini, O. M.
    Vitale, A.
    Obici, L.
    Sota, J.
    Frediani, B.
    Merlini, G.
    Rigante, D.
    Cantarini, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (06) : 159 - 160
  • [27] Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes
    Aganna, E
    Hammond, L
    Hawkins, PN
    Aldea, A
    McKee, SA
    van Amstel, HKP
    Mischung, C
    Kusuhara, K
    Saulsbury, FT
    Lachmann, HJ
    Bybee, A
    McDermott, EM
    La Regina, M
    Arostegui, JI
    Campistol, JM
    Worthington, S
    High, KP
    Molloy, MG
    Baker, N
    Bidwell, JL
    Castañer, JL
    Whiteford, ML
    Janssens-Korpola, PL
    Manna, R
    Powell, RJ
    Woo, P
    Solis, P
    Minden, K
    Frenkel, J
    Yagüe, J
    Mirakian, RM
    Hitman, GA
    McDermott, MF
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : 2632 - 2644
  • [28] Tumour necrosis factor receptor-associated periodic syndrome.: A rare differential diagnosis of multiple sclerosis
    Günther, P
    Minden, K
    Hermann, W
    Schneider, JP
    Wagner, A
    NERVENARZT, 2005, 76 (10): : 1263 - 1266
  • [29] Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome
    Torene, Rebecca
    Nirmala, Nanguneri
    Obici, Laura
    Cattalini, Marco
    Tormey, Vincent
    Caorsi, Roberta
    Starck-Schwertz, Sandrine
    Letzkus, Martin
    Hartmann, Nicole
    Abrams, Ken
    Lachmann, Helen
    Gattorno, Marco
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (01) : 303 - 309
  • [30] A nephrotic patient with tumour necrosis factor receptor-associated periodic syndrome, IgA nephropathy and CNS involvement
    Rudofsky, G
    Hoffmann, F
    Müller, K
    Filser, M
    Lohse, P
    Beimler, J
    Schwenger, V
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (04) : 1109 - 1112